There were 637 press releases posted in the last 24 hours and 440,888 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image